Cover Image

Reporting of adverse events and the fundamental tasks of managers-A qualitative interview study

Abstract Aim To describe healthcare professionals' experiences of adverse event reporting in relation to the fundamental tasks of managers. Design Qualitative interview study. Method Twenty‐four semi‐structured interviews including six managers, six medical doctors, six Registered Nurses and si...

Full description

Saved in:

Bibliographic Details
Main Authors:	Karin Birk Tot (Author), Mirko Markič (Author), Ljubiša Pađen (Author)
Format:	Book
Published:	Wiley, 2023-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparing the application of two theoretical frameworks to describe determinants of adverse medical device event reporting: secondary analysis of qualitative interview data
by: Laura Desveaux, et al.
Published: (2018)

PRACTICAL ASPECTS OF THE INTERNATIONAL CODE OF MARKETING OF BREAST-MILK SUBSTITUTES - NARRATIVE REVIEW
by: Renata Vettorazzi, et al.
Published: (2023)

MEDNARODNI KODEKS O TRŽENJU NADOMESTKOV MATERINEGA MLEKA V PRAKSI - NARATIVNI PREGLED LITERATURE
by: Renata Vettorazzi, et al.
Published: (2023)

Patient voice on management of facial dermatological adverse events with targeted therapies: a qualitative study
by: Kaori Yagasaki, et al.
Published: (2019)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)

Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2022)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024)

NURSES' KNOWLEDGE ABOUT ADVERSE EVENTS AND THE CHALLENGES OF REPORTING THESE EVENTS
by: Jamilly Santos Araujo, et al.
Published: (2016)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021)

Exploring everyday work as a dynamic non-event and adaptations to manage safety in intraoperative anaesthesia care: an interview study
by: Karolina Olin, et al.
Published: (2023)

Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)
by: Yiwen Bao, et al.
Published: (2024)

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
by: Kaibin Niu, et al.
Published: (2024)

Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
by: Yujin Choi, et al.
Published: (2024)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
by: Pan Ma, et al.
Published: (2022)

Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system
by: Qiang Guo, et al.
Published: (2022)

Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database
by: Zhengkang Su, et al.
Published: (2024)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
by: Matthew S. Duprey, et al.
Published: (2019)

ANALYSIS OF ADVERSE EVENT REPORTING AT ACCREDITED HOSPITALS
by: Tatiana Paula Miguelaci Ferezin, et al.
Published: (2017)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022)

Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system
by: Liangxia Li, et al.
Published: (2024)

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system
by: Xianglin Pan, et al.
Published: (2024)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
by: Colleen M. Kingsbury, et al.
Published: (2024)

Incidence and management of the main serious adverse events reported after COVID‐19 vaccination
by: Teresa Padilla‐Flores, et al.
Published: (2024)

A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam
by: Weizhen He, et al.
Published: (2024)

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021
by: Christine Learned, BA, et al.
Published: (2022)

Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system
by: Qiong Jie, et al.
Published: (2024)

Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020)

META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports
by: Milena M Murray, et al.
Published: (2023)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
by: Si Su, et al.
Published: (2023)

Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System
by: Giuseppe Cicala, et al.
Published: (2024)

Fundaments in the management of nvivo 9 as a tool for qualitative studies
by: Mª Ángeles Valdemoros-, et al.
Published: (2013)

Vemurafenib and cutaneous adverse events - report of five cases
by: Giselle de Barros Silva, et al.
Published: (2015)

The practice of reporting adverse events in a teaching hospital
by: Andréia Guerra Siman, et al.
Published: (2017)

Challenges and Solutions Facing Medical Errors and Adverse events in Iran: A Qualitative Study
by: Leila Doshmangir, et al.
Published: (2016)

Application of Multidimensional Quality Management Tools in the Management of Medical Adverse Events
by: Yuan B, et al.
Published: (2024)

Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS)
by: KaiLi Mao, et al.
Published: (2024)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
by: Hayato Katsuno, et al.
Published: (2021)

The application study of harmonization code in medical device adverse event reporting
by: Soo Jeong Choi, et al.
Published: (2024)

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib
by: Xusheng Zhang, et al.
Published: (2024)